SG93690G - Pyridazine derivatives active on the central nervous system,preparation process and medicines containing them - Google Patents

Pyridazine derivatives active on the central nervous system,preparation process and medicines containing them

Info

Publication number
SG93690G
SG93690G SG936/90A SG93690A SG93690G SG 93690 G SG93690 G SG 93690G SG 936/90 A SG936/90 A SG 936/90A SG 93690 A SG93690 A SG 93690A SG 93690 G SG93690 G SG 93690G
Authority
SG
Singapore
Prior art keywords
nervous system
preparation process
central nervous
pyridazine derivatives
medicines containing
Prior art date
Application number
SG936/90A
Other languages
English (en)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SG93690G publication Critical patent/SG93690G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG936/90A 1983-01-27 1990-11-19 Pyridazine derivatives active on the central nervous system,preparation process and medicines containing them SG93690G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
SG93690G true SG93690G (en) 1991-01-18

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
SG936/90A SG93690G (en) 1983-01-27 1990-11-19 Pyridazine derivatives active on the central nervous system,preparation process and medicines containing them

Country Status (27)

Country Link
US (1) US4721711A (enExample)
EP (1) EP0117779B1 (enExample)
JP (1) JPS59141564A (enExample)
KR (1) KR910000638B1 (enExample)
AR (1) AR240045A1 (enExample)
AT (1) ATE48417T1 (enExample)
AU (2) AU2372984A (enExample)
CA (1) CA1238637A (enExample)
DD (1) DD220026A5 (enExample)
DE (1) DE3480653D1 (enExample)
DK (1) DK162985C (enExample)
ES (1) ES529081A0 (enExample)
FI (1) FI78691C (enExample)
FR (1) FR2540113A1 (enExample)
HU (1) HU193890B (enExample)
IE (1) IE57054B1 (enExample)
IL (1) IL70756A (enExample)
MA (1) MA20018A1 (enExample)
NO (1) NO840313L (enExample)
NZ (1) NZ206945A (enExample)
OA (1) OA07644A (enExample)
PH (1) PH21162A (enExample)
PL (1) PL142340B1 (enExample)
PT (1) PT77993B (enExample)
SG (1) SG93690G (enExample)
YU (1) YU14284A (enExample)
ZA (1) ZA84502B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
EP0190563B1 (de) * 1985-01-14 1989-08-02 Boehringer Ingelheim Kg Neue 12-Amino-pyridazino[4',5':3,4]pyrrolo-[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
US20030176437A1 (en) * 2001-08-31 2003-09-18 D.M. Watterson Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
CA2589102C (en) * 2004-11-02 2013-08-13 Northwestern University Pyridazine compounds and methods for using the compounds to treat inflammatory diseases
MX2007005247A (es) 2004-11-02 2008-03-13 Univ Northwestern Compuestos de piridazina, composiciones y metodos.
US20100168120A1 (en) * 2006-04-28 2010-07-01 Neuromedix Inc. Salts of pyridazine compounds
AU2007243280A1 (en) * 2006-04-28 2007-11-08 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
EP2015750A2 (en) * 2006-04-28 2009-01-21 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
CN101668732A (zh) * 2007-04-02 2010-03-10 同一世界健康研究院 Cftr抑制剂化合物及其用途
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
WO2009131947A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising pyridazine derivatives
US20090264433A1 (en) * 2008-04-21 2009-10-22 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Triazine Derivatives
US8207205B2 (en) * 2008-04-21 2012-06-26 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
WO2010033626A1 (en) * 2008-09-19 2010-03-25 Institute For Oneworld Health Compounds, compositions and methods comprising imidazole and triazole derivatives
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions

Also Published As

Publication number Publication date
AR240045A1 (es) 1990-01-31
DD220026A5 (de) 1985-03-20
FI78691C (fi) 1989-09-11
FI840323L (fi) 1984-07-28
DK162985C (da) 1992-06-01
PT77993A (fr) 1984-02-01
ATE48417T1 (de) 1989-12-15
US4721711A (en) 1988-01-26
FR2540113A1 (fr) 1984-08-03
IE57054B1 (en) 1992-04-08
EP0117779B1 (fr) 1989-12-06
YU14284A (en) 1986-12-31
IE840149L (en) 1984-07-27
PH21162A (en) 1987-08-05
AU652118B2 (en) 1994-08-18
PL142340B1 (en) 1987-10-31
DK38984D0 (da) 1984-01-27
PT77993B (fr) 1986-04-10
DK162985B (da) 1992-01-06
FI840323A0 (fi) 1984-01-26
EP0117779A1 (fr) 1984-09-05
IL70756A0 (en) 1984-04-30
ZA84502B (en) 1984-09-26
ES8500243A1 (es) 1984-10-01
HU193890B (en) 1987-12-28
NZ206945A (en) 1987-07-31
KR840007586A (ko) 1984-12-08
KR910000638B1 (ko) 1991-01-31
FR2540113B1 (enExample) 1985-05-17
CA1238637A (en) 1988-06-28
AU2142188A (en) 1989-03-16
DK38984A (da) 1984-07-28
DE3480653D1 (de) 1990-01-11
NO840313L (no) 1984-07-30
FI78691B (fi) 1989-05-31
PL245931A1 (en) 1985-07-16
AU2372984A (en) 1984-08-02
IL70756A (en) 1987-03-31
ES529081A0 (es) 1984-10-01
MA20018A1 (fr) 1984-10-01
JPS59141564A (ja) 1984-08-14
OA07644A (fr) 1985-05-23

Similar Documents

Publication Publication Date Title
SG93690G (en) Pyridazine derivatives active on the central nervous system,preparation process and medicines containing them
AU578703B2 (en) Dialkoxypyridines, process for their preparation, their use and medicaments containing them
PT84087A (en) Process for the preparation of 2-oxo-1,3-dioxolaned and of polyurethanesyntetic resins containing the same
OA08707A (en) Tertiary hydroxyalkylxanthines, processes for their preparation, medicaments containing them and their use.
IL81184A0 (en) Diarylalkyl-substituted alkylamines,processes for their preparation,their use,and medicaments containing them
EP0188388A3 (en) Alpha-alumina particles, and process for preparing the same
EP0187620A3 (en) Pyrrolo-pyrroles, process for their preparation and use
IL83509A0 (en) Pyrimidine derivatives,their manufacture and medicaments containing them
PH19739A (en) W-cyano-1,w -diphenyl-azaalkane derivatives,their preparation and drugs containing them
DE3262671D1 (en) Amino-pyridazine derivatives active on the central nerve system
PH22975A (en) Substituted hydrazones, process for the preparation and their use
DE3263462D1 (en) Azepine derivatives, their preparation and medicaments containing them
DE3273893D1 (en) Pyridazine derivatives active on the central nerve system
YU202886A (en) Process for capsulating non-steroide antiflamatoric medicines
DE3469026D1 (en) Pyridazine derivatives with a psychotrope activity, process for their preparation, intermediates and medicines containing them
IL81676A0 (en) Naphthothiazepinones,their manufacture and medicaments containing them
AR242389A1 (es) Procedimiento para preparar -di-(n-alquil c1-c4)-amino-4,5-dihidroimidazo¡1,2-a¿quinazolin-2(1h)-onas.
ZA854287B (en) Dialkoxypyridines,process for their preparation,their use and medicaments containing them
DE3368061D1 (en) Azabicycloalkane derivatives, their preparation and medicaments containing them
GR890300066T1 (en) Dihydropyridazinone derivatives, method for their preparation and medicines containing the compounds
ZA85655B (en) Hydantoin derivatives,process for producing the same and medicine containing the same
EP0226642A4 (en) BENZOYL UREA COMBATINGS, THEIR PRODUCTION METHOD AND PEST CONTROL.
ZA845397B (en) Pyrrolidinones active on the central nervous system,process for their preparation and medicaments containing them
ZA876305B (en) 3-perfluoroalkyl-5-substituted-oxy-isoxazole derivatives,process for preparing the same,and herbicides containing the same
EP0134247A4 (en) PROTEIN WITH ONCOSTATIC EFFECT, PREPARATION METHOD THEREOF, AND ONCOSTATIC MEDICENT CONTAINING THE SAME.